Homeownership Program Review
As part of the ongoing Homeownership Program Review process, the Housing Division is inviting current owners of affordable homes to attend an information and feedback session. These meetings are being held to provide an overview of the proposed recommendations to some of the program terms, including the way units increase in value and whether units can be passed through inheritance.
Cambridge Announces $2.5 Million Restaurant and Nightlife Relief Grant Program
The City of Cambridge announced a new Restaurant and Nightlife Relief Grant program today which will award $2,500,000 to eligible Cambridge venues. These grants, funded through the American Rescue Plan Act (ARPA), will provide relief to local, non-franchise cafes, restaurants, and entertainment venues (e.g. movie theaters, performance venues, galleries) heavily impacted by the ongoing COVID-19 pandemic. Restaurants and entertainment venues citywide will be able to apply for grant awards of $10,000 for allowable business expenses such as payroll, rent, personal protective equipment, utilities, goods and equipment, and outdoor dining infrastructure. Applications will be accepted from February 3-28, 2022 at 8:00 p.m.
Getting Your Teen Vaccinated: Where to Find the Pfizer Vaccine
People age 18 and older can get any vaccine, but teens age 12 to 17 can only get the Pfizer vaccine. Mass vaccination sites in Boston offer the Pfizer vaccine, as well as some Cambridge pharmacies, and the CHA Somerville, Medford, and Everett vaccination sites.
Baker-Polito Administration Initiates Transition to First Phase of Four-Phase Approach
The Baker-Polito Administration released Reopening Massachusetts, the Reopening Advisory Board’s report, which details a four-phased strategy to responsibly reopen businesses and activities while continuing to fight COVID-19. The Administration also released a new “Safer At Home” Advisory, which instructs residents to stay at home unless engaging with newly opened activities, as a way to continue limiting the spread of COVID-19.